Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/20/21
End: 11/10/22
Due: 11/10/23
Phase: N/A
Priority: Normal
Start: 08/20/22
End: 10/10/23
Due: 10/10/24
Phase: N/A
Priority: Normal
Start: 02/15/21
End: 05/22/22
Due: 05/22/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study With Heparin Sodium in Intravenous Administration | NCT03125187 | União Química Farmacêutica Nacional S/A | user2@example.com | None | 2021-02-20 | 2022-11-10 | 2023-11-10 | - | - | 2025-07-14 |
| Study With Heparin Sodium in Subcutaneous Administration | NCT03113084 | União Química Farmacêutica Nacional S/A | user2@example.com | None | 2022-08-20 | 2023-10-10 | 2024-10-10 | - | - | 2025-07-14 |
| Study of Amblyomin-X in Advanced Solid Tumor | NCT03120130 | União Química Farmacêutica Nacional S/A | user2@example.com | None | 2021-02-15 | 2022-05-22 | 2023-05-22 | - | - | 2025-07-14 |